University Medical Center Groningen — Clinical Trial Site

13 Registered trials

7 Currently recruiting

Organisation

University Medical Center Groningen

Location

Groningen, Netherlands

Identifier

ORL-000003959

Address

Hanzeplein 1, 9713 GZ, Netherlands

Departments

Center for Clinical Neuroscience and Cognition
Critical Care
Department of Gastroenterology and Hepatology
Department of Neurology
Haematology
Internal Medicine - Endocrinology
Interne geneeskunde / infectieziekten
Nephrology
Obstetrics
Pulmonary Medicine
Respiratory disease, tuberculosis and lung transplantation
Rheumatology

Clinical trials at this site (13)

Search interface

Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI… Not authorised

2024-514693-47-00 EGFR mutated locally advanced or metastatic non-small c 11
A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised

2025-523060-20-00 Schizophrenia 5
Randomized controlled trial comparing immediate versus extended release tacrolimus; reducing calcineurin inhibitor related toxicity in lung … Pending

2024-518639-12-00 lung transplantation 5
[68Ga]FAPI PET/CT to detect fibroblast activity in pulmonary COVID patients with and without long-term health problems. Recruiting

2024-517931-29-00 post-acute sequelae of COVID-19 11 2025-07-01
Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI… Recruiting

2024-514693-47-01 EGFR mutated locally advanced or metastatic non-small c 11 2025-10-28
Safety and Efficacy of Intravenous Thrombolysis in Patients with Ischemic Stroke on Treatment with Direct Oral Anticoagulants: DO-IT – The D… Recruiting

2024-515561-34-01 Acute ischemic stroke with recent ingestion of direct o 6 2025-08-04
Positron emission tomography with macrophage targeting to select individuals at risk for rheumatoid arthritis. Recruiting

2024-513538-40-02 ACPA positive arthralgia 4 2024-12-09
Subtyping Primary Aldosteronism with Para-chloro-2-[18F]fluoroethyl-etomidate ([18F]CETO) Recruiting

2023-508254-26-00 Primary aldosteronism 7 2024-11-06
STRATIFY; Near-infrared fluorescence molecular imaging of adalimumab-800CW to elucidate the drug distribution throughout inflamed tissue in … Recruiting

2024-513390-50-00 Crohn's disease 3 2024-08-06
A randomized trial to investigate the reset of humoral autoimmunity by combining belimumab with rituximab in severe systemic lupus erythemat… Recruiting

2023-507867-20-00 Lupus Erythematosus, Systemic 10 2018-10-04
POEM Study Ended

2024-519386-21-01 Gestational diabetes mellitus 5 2025-01-29
TURN-COVID Biobank: The Dutch cohort study for the evaluation of the use of neutralizing monoclonal antibodies and other antiviral agents ag… Ended

2024-515263-60-00 SARS-CoV-2 infection 6 2024-11-22
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Plac… Ended

2024-511066-36-00 Light Chain (AL) Amyloidosis 5 2021-10-13